Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate + CBT in Obese BED
NCT00307619Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in binge eating disorder (BED) and obesity comparing Topiramate + CBT with Placebo + CBT (2 arms). Primary endpoints: Body Weight, Body Mass Index and 2 more. Started Nov 2003; status: completed.
02
Drugs
topiramate
03
Conditions
binge eating disorder (BED)obesity
Beyond the preview
Go deeper on NCT00307619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307619.